
zzso cell zzso vaccination is a promising strategy for cancer zzso However, clinical trials have indicated that zzso zzso induced by tumors profoundly suppress zzso immunity and inhibit vaccine zzso resulting in insufficient reduction of tumor zzso To overcome these obstacles and enhance the efficiency of DC zzso we generated zzso zzso and zzso zzso factor zzso zzso zzso zzso as suitable therapeutic zzso to eliminate immune suppression and promote DC zzso By treating tumors with zzso prior to DC zzso zzso zzso greater zzso effects than in response to either treatment zzso DC migration to draining zzso zzso zzso dramatically increased in mice treated with the combination zzso This result was associated with zzso of zzso zzso 21 zzso zzso in tumors treated with zzso Moreover, the proportion of zzso zzso and vascular zzso growth factor zzso expression was decreased in mice treated with the combination zzso Furthermore, combination therapy using immature zzso also showed effective zzso effects when combined with zzso The combination therapy had a remarkable therapeutic efficacy on large zzso Taken together, zzso zzso zzso zzso and zzso in combination with DC vaccination has synergistic zzso effects and can act as a potent zzso for promoting and zzso DC zzso 

